Rheumatoid arthritis

Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study

J RheumatolPublished Retrospective cohort study

Authors' conclusion

This study did not identify any sex difference in the use of DMARDs among older patients with RA and PsA.

Study context

Population
Patients with incident rheumatoid arthritis (RA) and psoriatic arthritis (PsA) aged ≥ 66 years at diagnosis, Ontario, Canada (2010–2017)13,613 RA (64% female)
Exposure
Older female vs male patients with early RA and PsA
Outcome
Yearly dispensation of rheumatic drugs (csDMARDs, advanced therapy, nonsteroidal antiinflammatory drugs (NSAIDs), opioids, oral corticosteroids)
Follow-up
3 years after diagnosis
Methodological detailspopulation-based, health administrative data, multivariable regression adjusted for confounders
  • Population-based
  • Health administrative data
  • Multivariable regression adjusted for confounders

Main finding

As reported in the abstract

Dispensation of disease-modifying antirheumatic drugs (DMARDs)
  • No sex difference in DMARD dispensation in either RA or PsA

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Opioid dispensation, RAFemalevs MaleRange across years: lowest of OR 1.39 to OR 1.511.39 (1.22–1.58)
Opioid dispensation, RAFemalevs MaleRange across years: highest of OR 1.39 to OR 1.511.51 (1.32–1.72)
NSAID dispensation, RAFemalevs MaleRange across years: lowest of OR 1.14 to OR 1.161.14 (1.04–1.25)
NSAID dispensation, RAFemalevs MaleRange across years: highest of OR 1.14 to OR 1.161.16 (1.04–1.30)

Patient–physician sex concordance (subgroup)

More intense use of advanced therapy in RA and of csDMARDs in PsA when patient and physician sex concordant

Original publication

Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study. J Rheumatol. Published 1 May 2024. doi:10.3899/jrheum.2023-1148

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.